FindTrial
Sign In

Inferior Vena Cava–Splenic Vein Shunt (IVCSS) versus Portal Vein Recanalization–Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) for Variceal Bleeding Due to Portal Hypertension in Cirrhotic Patients with Complete Portal Trunk Occlusion: A Retrospective Study

Inferior Vena Cava–Splenic Vein Shunt (IVCSS) versus Portal Vein Recanalization–Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) for Variceal Bleeding Due to Portal Hypertension in Cirrhotic Patients with Complete Portal Trunk Occlusion: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108867
Enrollment
Unknown
Registered
2025-09-08
Start date
2025-09-08
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis with portal hypertension

Interventions

Inferior vena cava - splenic vein shunt:None
portal vein recanalization-TIPS:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age range: 20 - 70 years old; Eastern Cooperative Oncology Group score = 2; and complete occlusion of the main portal vein confirmed by enhanced CT or MRI

Exclusion criteria

Exclusion criteria: Extensive occlusion of the splenic vein or mesenteric vein; Child-Pugh score >= 14.

Design outcomes

Primary

MeasureTime frame
Technical success rate;—

Secondary

MeasureTime frame
Incidence rate of adverse events;—

Countries

China

Contacts

Public ContactGao Fei

Sun Yat-sen University Cancer Center

gaof@sysucc.org.cn+86 137 6086 9828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026